A NYSCF – Supported Cell Therapy for Parkinson’s Disease is Entering Clinical Trials
A major hallmark of Parkinson’s disease is the loss of dopamine-producing neurons in the brain, which in turn causes patients to lose motor control abilities. NYSCF...